研究成果
年分
作者
期刊
研究名稱
Chang TY, Lip GYH, Chen SA, Chao TF*.
Can. J. Cardiol. 2019; 35(5) 611-618. (IF: 5.592) 342-344 (IF: 1.676)
Importance of Risk Reassessment in Patients With Atrial Fibrillation in Guidelines: Assessing Risk as a Dynamic Process.
Vasquez N, Ostrander BT, Lu DY, Ventoulis I, Haileselassie B, Goyal S, Greenland GV, Vakrou S, Olgin JE, Abraham TP, Abraham MR*.
J. Am. Soc. Echocardiogr. 2019; 32(5) 593-+ (IF: 6.111)
Low Left Atrial Strain Is Associated With Adverse Outcomes in Hypertrophic Cardiomyopathy Patients.
Wei JH*, Lee WJ, Lin SJ, Huang PH.
Surg. Obes. Relat. Dis. 2019; 15(2) 353-354. (IF: 3.758)
Reply letter to the editor metabolic surgery ameliorates cardiovascular risk in obese diabetic patients: influence of different surgical procedures.
Chao TF*, Chiang CE, Chen TJ, Lip GYH, Chen SA.
Ann. Intern. Med. 2019; 170(9) 663-+ (IF: 19.315)
Reassessment of Risk for Stroke During Follow-up of Patients With Atrial Fibrillation.
Chang HC, Cheng HM*.
J. Clin. Hypertens. 2019; 21(5) 616-617. (IF: 2.444)
P wave peak time: A time window to evaluate left ventricular diastolic function.
Song HY, Chien CS, Yarmishyn AA, Chou SJ, Yang YP, Wang ML, Wang CY, Leu HB, Yu WC, Chang YL, Chiou SH.
Cells. 2019;8(4):327.
Generation of GLA-Knockout Human Embryonic Stem Cell Lines to Model Autophagic Dysfunction and Exosome Secretion in Fabry Disease-Associated Hypertrophic Cardiomyopathy.
Lin YJ*, Lin CY, Chen SA.
Curr. Opin. Cardiol. 2019; 34(1) 16-22. (IF: 1.979)
Ablation of persistent atrial fibrillation and beyond.
Chen CY, Hsu SC, Hsieh HL, Suk CW, Hsu YP, Sue YM, Chen OH, Lin FE, Shih CM, Chen AW, Lin SO, Huang PS, Liu CT*.
PLoS One. 2019; 14(5)- (IF: 2.776)
Microbial etiology of pneumonia in patients with decreased renal function.
Cheng HM, Sung SH, Chen CH, Yu WC, Yang SM, Guo CY, Chuang SY, Chiang CE*.
Trials. 2019;20(1):265.
Guiding Hypertension Management Using Different Blood Pressure Monitoring Strategies (GYMNs study): comparison of three different blood pressure measurement methods: study protocol for a randomized controlled trial.
Pang J, Chan DC, Hu M, Muir LA, Kwok S, Charng MJ*, Florkowski CM, George PM, Lin J, Loi DD, Marais AD, Nawawi HM, Gonzalez-Santos LE, Su TC, Truong TH, Santos RD, Soran H, Tomlinson B, Yamashita S, Ademi Z, Watts GF.
J. Clin. Lipidol. 2019; 13(2) 287-300. (IF: 3.581)
48.
49. Trials. 2019; 20() (IF:)
50. Comparative aspects of the care of familial hypercholesterolemia in the "Ten Countries Study".